Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

被引:0
|
作者
Hung Huynh
Richard Ong
Khee Chee Soo
机构
[1] National Cancer Centre,Laboratory of Molecular Endocrinology, Division of Molecular and Cellular Research
来源
Angiogenesis | 2012年 / 15卷
关键词
Foretinib; HCC; Growth inhibition; Angiogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:59 / 70
页数:11
相关论文
共 50 条
  • [1] Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma
    Huynh, Hung
    Ong, Richard
    Soo, Khee Chee
    ANGIOGENESIS, 2012, 15 (01) : 59 - 70
  • [2] RNAi mediated inhibition of beta-catenin demonstrates anti-tumor efficacy and immune microenvironment modulation in preclinical hepatocellular carcinoma models
    Dadali, Tulin
    Miller, Spencer
    Saawant, Gaurav
    Abbott, Stephen
    Yu, Mikyung
    Morskaya, Svetlana
    Lehrich, Brandon
    Monga, Satdarshan
    Lau, Gloria
    Maier, Martin
    Broom, Wendy
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Anti-tumor efficacy and safety of AEV01 in preclinical glioblastoma and hepatocellular carcinoma models
    Biswas, Indrani
    Precilla, Senthilathiban Daisy
    Kumar, Aravinda
    Sekhar, M. M.
    Medasani, Renu
    Anitha, T. S.
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [4] Preclinical assessment of anti-tumor activity and immune response in syngeneic tumor models
    Franklin, M.
    Thayer, M.
    Draper, D.
    Saims, D.
    Wise, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S97 - S97
  • [5] Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma
    Nagel, Carmen
    Armeanu-Ebinger, Sorin
    Dewerth, Alexander
    Warmann, Steven W.
    Fuchs, Joerg
    EXPERIMENTAL CELL RESEARCH, 2015, 331 (01) : 97 - 104
  • [6] Targeting TBL1 with tegavivint promotes anti-tumor and immunomodulatory responses in preclinical models of hepatocellular carcinoma
    Holloway, Kimberly R.
    Drake, Thomas
    Bird, Thomas
    Horrigan, Stephen
    CANCER RESEARCH, 2023, 83 (07)
  • [7] PRECLINICAL ANTI-TUMOR ACTIVITY OF XL880 IN NASOPHARYNGEAL CARCINOMA
    Xie, M.
    Li, Z.
    ANNALS OF ONCOLOGY, 2012, 23 : 337 - 337
  • [8] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wei-De Wu
    Pin-Shern Chen
    Hany A. Omar
    El-Shaimaa A. Arafa
    Hung-Wei Pan
    Jingyueh Jeng
    Jui-Hsiang Hung
    Scientific Reports, 8
  • [9] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wu, Wei-De
    Chen, Pin-Shern
    Omar, Hany A.
    Arafa, El-Shaimaa A.
    Pan, Hung-Wei
    Jeng, Jingyueh
    Hung, Jui-Hsiang
    SCIENTIFIC REPORTS, 2018, 8
  • [10] BTK inhibitor BGB-3111 demonstrates anti-tumor activity in solid tumor models
    Hu, Nan
    Zhang, Jiye
    He, Min
    Zhang, Shuo
    Liu, Yong
    Wang, Lai
    CANCER RESEARCH, 2017, 77